-
Cryptosporidium AdhE: Imidazole Inhibition and Efficacy
2026-08-22
The reference study identifies the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a metabolic vulnerability in Cryptosporidium parvum. Screening of 3,892 chemical entries produced low-micromolar enzyme inhibitors, and three antifungal imidazoles also suppressed parasite growth in vitro, providing an early target-to-cell proof of concept for anti-cryptosporidial drug discovery.
-
Carbenoxolone disodium: Practical Lab Guide
2026-08-21
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor used to examine glucocorticoid access, corticosterone metabolism, and gap junction communication in cell and tissue workflows. It is best treated as an exploratory mechanistic reagent rather than a selective target-validation compound or an in vivo efficacy treatment.
-
Cyanine 3 Tyramide: Signal Amplification Guide
2026-08-21
Cyanine 3 Tyramide is an orange fluorescent dye for biomedical research that supports enzyme-driven signal amplification in tissue, nucleic-acid, and cell-labeling workflows. Its solid format, DMSO solubility, and light-protected storage support controlled preparation for Tyramide Signal Amplification experiments.
-
Clarithromycin as a CYP3A Assay Perturbation
2026-08-20
Clarithromycin is more than a CYP3A inhibitor: it can function as a mechanistic perturbation for separating metabolic inhibition from transporter, renal, and exposure effects. This guide integrates dabigatran pharmacology with assay design, controls, interpretation, and reagent handling for drug-drug interaction research.
-
Gly-Gly-Phe-Gly: Linker Logic for Better Assays
2026-08-20
Gly-Gly-Phe-Gly (GGFG) is more than a flexible peptide spacer: its sequence can help define how conjugates are interpreted in drug conjugation research. This article connects GGFG peptide design with assay controls, mechanistic evidence, and lessons from a calcineurin-targeting multiple myeloma study.
-
Ciprofloxacin Beyond Antibiotic Assays
2026-08-19
Ciprofloxacin is more than a benchmark fluoroquinolone antibiotic: its molecular behavior can inform both bacterial assays and emerging ultrasound-responsive nanotheranostics. This article explains how to translate its mechanism into better controls, endpoints, and interpretation without confusing antibacterial activity with formulation-dependent cancer effects.
-
nor-NOHA: An Assay Strategy for Immune Metabolism
2026-08-19
Explore how nor-NOHA acetate can resolve arginase-dependent effects from CD36-driven immune escape in cancer models. This assay-focused guide connects arginine metabolism, HepG2 phenotypes, vascular biology, and AML study design without overstating translational evidence.
-
MroGCL and Early Spermatogenesis in Giant Prawn
2026-08-18
Molcho and colleagues identified and functionally tested MroGCL, a germ cell-less homolog in Macrobrachium rosenbergii, linking its expression to gonadal development and early spermatogenesis. The study provides evidence that MroGCL supports sperm production during early mitotic stages, while also showing that its role is partial and biologically context-dependent rather than an all-or-none requirement for advanced spermatogenesis.
-
Iterative Discovery of TAS2R14 Bitter Taste Ligands
2026-08-18
The 2023 study developed an iterative experimental–computational strategy to identify ligands for the highly promiscuous bitter taste receptor TAS2R14 despite the absence of an experimental receptor structure. Screening clinically used drugs and synthesizing flufenamic acid derivatives produced 10 new antagonists and 200 new agonists, while progressively improving the receptor model for structure-based discovery.
-
Dhx9 Helicase Orchestrates TH17 Autoimmunity
2026-08-17
The reference study identifies the nuclear helicase Dhx9 as a chromatin-level regulator of TH17 lineage commitment, linking IL-6–STAT3 signaling to accessibility at the Rorc and Il17 loci. Genetic deletion and pharmacological inhibition reduced TH17 differentiation and autoimmune disease severity in mouse models, providing a mechanistic framework for targeting transcriptional programs rather than individual inflammatory cytokines.
-
Doxorubicin Workflows for Drug-Resistance Research
2026-08-16
Build reproducible Doxorubicin and Adriamycin assays for DNA damage, apoptosis, and multidrug-resistance studies. This guide connects concentration-controlled cell workflows with the SMYD2–miR-125b–P-glycoprotein findings reported in renal cell carcinoma.
-
Piezo1, Caspase-8, and Cardiac PANoptosis
2026-08-15
The reference study identifies Piezo1 as a mechanosensitive channel that worsens myocardial ischaemia/reperfusion injury through caspase-8-associated PANoptosis. Its combined mouse and cardiomyocyte experiments distinguish calcium influx from the caspase-8-dependent execution of inflammatory cell death, providing a useful framework for mechanistic cardiac injury studies.
-
Pseudo-UTP B7972 for Reliable RNA Assays
2026-08-15
Learn when Pseudo-UTP is useful in RNA-driven cell viability, proliferation, and cytotoxicity workflows, and how SKU B7972 supports controlled in vitro transcription. The article connects pseudouridine modification, assay design, handling, interpretation, and practical supplier selection without overstating evidence.
-
Vernakalant Hydrochloride: AF Research Workflow
2026-08-14
Build a reproducible atrial fibrillation research workflow around Vernakalant Hydrochloride (RSD1235), from ion-channel assays to exposure–response interpretation. The guide emphasizes atrial selectivity, frequency-dependent sodium-channel block, formulation control, and practical troubleshooting for translational studies.
-
BMS-777607: Selective c-Met Inhibitor Profile
2026-08-14
BMS-777607 is an orally available, ATP-competitive c-Met inhibitor with activity across the MET receptor family. Product data report nanomolar inhibition of c-Met, Axl, Ron, and Tyro3, plus reduced lung tumor nodules in a murine KHT cancer metastasis model.
450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page